Next Article in Journal
Lagrangian Coupling of Dissipative Electrodynamic Waves with the Thermal Absorption and Emission
Next Article in Special Issue
Thioureas Derived from (S)-1-(2-pyridyl)ethylamine Enantiomer: Synthesis and Selected Applications as an Organocatalyst
Previous Article in Journal
A New Method of Teaching Quality Evaluation Based on the α-Pessimistic Shapley Value
Previous Article in Special Issue
Myrtenal and Myrtanal as Auxiliaries in the Synthesis of Some C,P-Stereogenic Hydroxyphosphine Oxides and Hydroxyphosphine-Boranes Possessing up to Four Contiguous Centers of Chirality
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis of α-Hydroxyethylphosphonates and α-Hydroxyethylphosphine Oxides: Role of Solvents During Optical Resolution

by
Zsuzsanna Szalai
1,
Anna Sára Kis
1,
József Schindler
1,*,
Konstantin Karaghiosoff
2 and
György Keglevich
1,*
1
Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Műegyetem rkp. 3, 1111 Budapest, Hungary
2
Department Chemie, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, D-81377 München, Germany
*
Authors to whom correspondence should be addressed.
Symmetry 2024, 16(11), 1557; https://doi.org/10.3390/sym16111557
Submission received: 29 October 2024 / Revised: 16 November 2024 / Accepted: 19 November 2024 / Published: 20 November 2024

Abstract

:
Five chiral, racemic dialkyl α-hydroxyethylphosphonates and α-hydroxyethyl-diarylphosphine oxides were prepared in a scalable manner. Possibilities for the optical resolution of the racemic hydroxyphosphine oxides were explored via diastereomeric complex-forming experiments. The acidic calcium salt of O,O′-dibenzoyl-(2R,3R)-tartaric acid and O,O′-di-p-tolyl-(2R,3R)-tartaric acid were chosen as the resolving agents. The role of the solvent in the enantiomeric discrimination was investigated. The diastereomeric complex could be obtained in a crystalline form for α-hydroxyethyl-diphenylphosphine oxide and α-hydroxyethyl-bis(4-methylphenyl)phosphine oxide. However, in the third case, for α-hydroxyethyl-bis(3,5-dimethylphenyl)phosphine oxide, there was no chiral discrimination. Decomposition of the recrystallized diastereomeric complex followed by decomposition of the complex yielded the target compounds in 77/90% enantiomeric excess. The absolute configuration of the hydroxyethyl-diphenylphosphine oxide was determined by single-crystal X-ray diffraction measurements. The interactions stabilizing the supramolecular associate were evaluated.

Graphical Abstract

1. Introduction

The outstanding and broad spectrum of biological properties of α-hydroxyphosphonates makes them indispensable in the family of enzyme inhibitors [1], herbicides [2], bactericides [3], fungicides [4], antioxidants [5], and cytotoxic agents [6,7]. In the pharmaceutical industry, it is essential to prepare biologically active compounds in an enantiomerically pure form. The enantiomers of racemic compounds may have different biological properties, and therefore, in most cases, the aim is to produce a single enantiomer [8,9]. Typically, this may be achieved by enantioselective syntheses [10,11,12] or the optical resolution of racemic compounds [13,14,15,16,17]. The most commonly used approach for the synthesis of optically active α-hydroxyphosphonates is the addition of dialkyl phosphites on the C=O group of the oxo compounds in the presence of a chiral organocatalyst [18,19,20]. Metal complexes containing chiral ligands may be used as catalysts instead of organocatalysts [21,22,23,24]. Another method involves the reaction of an oxo compound and a trialkyl phosphite in an enantioselective Abramov-type condensation [25]. Optically active α-hydroxyphosphonates may also be obtained by the asymmetric reduction of α-keto compounds [26,27,28]. Examples for the enantioselective oxidation of benzylphosphonates to α-hydroxyphosphonates have been also described [29,30]. As in the case of other hydroxy compounds, enantiomers of α-hydroxyphosphonates may also be prepared by enzyme-catalyzed kinetic acylation followed by the separation of the formed ester and the unchanged starting material [31]. This approach usually involves the selective acylation of one of the enantiomers of α-hydroxyphosphonate in the presence of an enzyme [32,33] or chiral organocatalyst [34]. Another way of resolution is to acylate the hydroxy group of hydroxyphosphonate with an optically active reagent to afford the products as diastereomeric mixtures. The diastereomers are then separated, for example, by chromatography. O,O′-dibenzoyl-(2R,3R)-tartaric acid anhydride is often used as a chiral derivatization agent. After the separation of the esters, the hydroxy compounds may be recovered by hydrolysis [35].
Earlier, we described the synthesis of racemic dialkyl 1-hydroxy-arylmethylphosphonates, whose structure was determined by single-crystal X-ray analysis [36]. In another article, we reported the synthesis and resolution of α-hydroxy-arylmethylphosphonates [37]. Previously, we successfully resolved cyclic phosphine oxides and phosphinates as related structures. We used the acid calcium salt of O,O′-dibenzoyl-(2R,3R)-tartaric acid [38] and TADDOL [39] as the resolving agents.
In this article, we report the scaled-up preparation of dialkyl-α-hydroxyethylphosphonates and α-hydroxyethyl-diarylphosphine oxides and the optical resolution of a part of the racemic compounds. Calcium hydrogen O,O′-dibenzoyl-(2R,3R)-tartrate and calcium hydrogen O,O′-di-p-tolyl-(2R,3R)-tartaric acid coordination complexes, well suited to our target molecules, were selected as the resolving agents.

2. Materials and Methods

2.1. General

The 31P, 13C, and 1H-NMR spectra were measured on a Bruker DRX-500 (Bruker, Billerica, MA, USA) or Bruker Avance-300 (Bruker, Billerica, MA, USA) spectrometer operating at 202, 126, and 500 MHz or 122, 75, and 300 MHz, respectively. The couplings were given in Hz. LC–MS measurements were performed with an Agilent 1200 liquid chromatography system coupled with a 6130 quadrupole mass spectrometer equipped with an ESI ion source (Agilent Technologies, Palo Alto, CA, USA). High-resolution mass spectrometric measurements were performed using a Thermo Velos Pro Orbitrap Elite (Thermo Fisher Scientific, Waltham, MA, USA) hybrid mass spectrometer in the positive electrospray mode.
The diastereomeric and enantiomeric excess (de and ee) values were determined by chiral HPLC on a Perkin Elmer Series 200 (PerkinElmer, Inc., Shelton, CT, USA) instrument equipped with chiral HPLC using Phenomenex Lux® i-Amylose-35 (Phenomenex, Torrance, CA, USA) µm column (150 × 4.6 mm ID, hexane/isopropyl alcohol 90:10 as an eluent with a flow rate of 1 mL/min, T = 25 °C, UV detector α = 254 nm). Retention times: 13.6 min for (S)-1c (for the other enantiomer, tret is 16.8 min); 28.5 min for (S)-1d (for the other enantiomer, tret is 36.7 min). Resolving agent Ca(H-DBTA)2 (2) and Ca(H-DpTTA)2 (3) [40] were prepared according to procedures reported by us.

2.2. General Procedure for the Synthesis of Dialkyl α-Hydroxyethylphosphonates (1a,b) or α-Hydroxyethyl-Diarylphosphine Oxides (1ce)

A 0.10 mol quantity of acetaldehyde (5.6 mL) and 0.05 mol of dialkyl phosphite (diethyl phosphite 6.4 mL, dibutyl phosphite 9.8 mL) or 0.05 mol of diarylphosphine oxide (diphenylphosphine oxide 10.1 g, bis(4-methylphenyl)phosphine oxide 11.5 g, bis(3,5-dimethylphenyl)phosphine oxide 12.9 g) and 0.05 mmol (7.0 mL) of triethylamine were stirred in 25 mL of ethyl acetate at 0 °C for 12 h.
In the case of 1a, 1b, and 1d, the mixture was evaporated under vacuum, and the crude products were purified by column chromatography (using ethyl acetate as the eluent on silica gel).
Hydroxyphosphine oxides 1c and 1e crystallized out from the reaction mixture. They were purified by recrystallization as follows: Crude products 1c (~12 g) and 1e (~15 g) were dissolved in toluene (100 mL), 600–750 mg (5%) of charcoal was added, and the mixture was stirred at the boiling point of toluene for 0.5 h. The mixture was filtered, and the charcoal was washed with toluene (10 mL). The solvent was evaporated so that the remaining mass of the residue should be ~30 g, and then, hexane (100 mL) was added dropwise to the mixture. After stirring for 2 h, the precipitated product was filtered off and washed with hexane (10 mL) to give product 1c in a yield of 97% (11.9 g) and compound 1e in a yield of 98% (14.8 g).
Products 1a and 1b are pale yellow oils, compound 1d is a viscous, colorless oil, and hydroxyphosphine oxides 1c and 1e are white crystalline compounds.

2.2.1. Diethyl α-Hydroxyethylphosphonate (1a)

Yield: 8.5 g (93%); pale yellow oil; 31P {1H} NMR (122 MHz, CDCl3) δ 25.9; δP,lit. [41] 27.9; [M + H]+ = 183; HRMS m/z: [M + Na]+ calculated for C6H15O4PNa 205.0606; found 205.0606.

2.2.2. Dibutyl α-Hydroxyethylphosphonate (1b)

Yield: 9.0 g (76%); pale yellow oil; 31P {1H} NMR (202 MHz, CDCl3) δ 25.8; δP,lit. [42] 25.8; [M + H]+ = 239; HRMS m/z: [M + Na]+ calculated for C10H23O4PNa 261.1232; found 261.1227.

2.2.3. α-Hydroxyethyl-Diphenylphosphine Oxide (1c)

Yield: 11.9 g (97%); white crystal; m.p.: 130–131 °C; m.p. [43] 131–132 °C; 31P {1H} NMR (202 MHz, CDCl3) δ 33.5; δP,lit. [44] 32.9; [M + H]+ = 247; HRMS m/z: [M + Na]+ calculated for C14H15O2PNa 269.0707; found 269.0704. [M + H]+ calculated for C14H16O2P 247.0888; found 247.0878.

2.2.4. α-Hydroxyethyl-Bis(4-Methylphenyl)phosphine Oxide (1d)

Yield: 11.5 g (84%); viscous, colorless oil; 31P {1H} NMR (202 MHz, CDCl3) δ 33.8; δP,lit. [45] 33.3; [M + H]+ = 275; HRMS m/z: [M + Na]+ calculated for C16H19O2PNa 297.1020; found 297.1018; [M + H]+ calculated for C16H20O2PNa 275.1201; found 275.1198.

2.2.5. α-Hydroxyethyl-Bis(3,5-Dimethylphenyl)phosphine Oxide (1e)

Yield: 14.8 g (98%); white crystal; m.p.: 192–193 °C; 31P {1H} NMR (202 MHz, CDCl3) δ 35.5; 13C {1H} NMR (126 MHz, CDCl3) δ 16.7 (d, J = 2.7 Hz, CCH3), 21.2 (d, J = 3.6 Hz, ArCH3), 66.2 (d, J = 83.4 Hz, CP), 128.7 (d, J = 9.0 Hz, Cβ), 129.2 (d, J = 8.7 Hz, Cβ), 129.4 (d, J = 95.2 Hz, Cα), 130.3 (d, J = 92.7 Hz, Cα), 133.7 (d, J = 2.8 Hz, Cδ), 133.8 (d, J = 2.9 Hz, Cδ), 138.1 (d, J = 12.2 Hz, Cγ), 138.3 (d, J = 11.9 Hz, Cγ); 1H NMR (500 MHz, CDCl3) δ 1.48 and 1.51 (d, J = 7.1 Hz, 3H, CCH3), 2.31 (s, 1H, OH), 2.38 (d, J = 3.8 Hz, 12H, ArCH3), 4.70–4.75 (m, 1H, CH), 7.23–7.50 (m, 6H, ArH); [M + H]+ = 303; HRMS m/z: [M + Na]+ calculated for C18H23O2PNa 325.1333; found 325.1330.

2.3. Procedure for the Preparation of Optically Active Ca[(S)-1c • H-DBTA]2 Complex

A mixture of 3.7 mmol (0.92 g) of α-hydroxyethyl-diphenylphosphine oxide (1c) and 0.93 mmol (0.69 g) of Ca(H-DBTA)2 was dissolved in 3.0 mL of ethanol and 30 mL of ethyl acetate at reflux. After the solution became clear, it was allowed to cool to 26 °C. After stirring for 24 h at 26 °C, the crystalline diastereomeric complex was filtered, and it was washed with 3 × 1.5 mL of ethyl acetate to give 0.55 g (yield = 48%) of Ca[(S)-1c • H-DBTA]2. To 3 mg of Ca[(S)-1c • H-DBTA]2, 0.5 mL of ethyl acetate and 0.05 mL of saturated Na2CO3 solution were added. After intense stirring, the organic phase was dried (Na2SO4), and the solvent was evaporated to afford (S)-1c with an enantiomeric excess of 38%.
The diastereomeric complex was purified by recrystallization: 1.4 mL of ethanol and 5.5 mL of ethyl acetate was added to the diastereomeric complex, and the suspension was heated at reflux until it became clear. The solution was allowed to cool to 26 °C, and it was stirred for 24 h at 26 °C. Filtration of the crystalline diastereomeric complex afforded 0.32 g (yield = 28%) of Ca[(S)-1c • H-DBTA]2.
To 3 mg of Ca[(S)-1c • H-DBTA]2, 0.5 mL of ethyl acetate and 0.05 mL of saturated Na2CO3 solution was added. After intense stirring, the organic phase was dried and evaporated to afford (S)-1c with an enantiomeric excess of 77%.

2.4. Procedure for the Preparation of Optically Active Ca[(S)-1d • H-DpTTA]2 Complex and Optically Active (S)-1d

A mixture of 0.55 mmol (0.15 g) of α-hydroxyethyl-bis(4-methylphenyl)phosphine oxide (1d) and 0.14 mmol (0.11 g) of Ca(H-DpTTA)2 was dissolved in 0.75 mL of ethanol and 3 mL of ethyl acetate at reflux. After the solution became clear, it was allowed to cool to 26 °C. After stirring for 24 h at 26 °C, the precipitated crystalline diastereomeric complex was filtered off, and the solid was washed with 3 × 0.5 mL of ethyl acetate to give 0.083 g (yield = 46%) of Ca[(S)-1d • H-DpTTA]2. To 3 mg of Ca[(S)-1d • H-DpTTA]2, 0.5 mL of ethyl acetate and 0.05 mL of saturated Na2CO3 solution were added. After intense stirring, the organic phase was dried (Na2SO4), and the solvent was evaporated to afford (S)-1d with an enantiomeric excess of 40%.
The diastereomeric complex was purified by recrystallization: 1 mL of ethanol and 5 mL of ethyl acetate was added to the diastereomeric complex, and the suspension was heated at reflux until it became clear. The solution was allowed to cool to 26 °C, and was stirred for 24 h at 26 °C. The precipitated diastereomeric complex was filtered off, and it was purified by recrystallization using the method described above. Filtration after the second recrystallization of the solid diastereomeric complex afforded 0.016 g (yield = 9%) of Ca[(S)-1d • H-DpTTA]2.
To 16 mg of Ca[(S)-1d • H-DpTTA]2 (de = 90%), 0.5 mL of ethyl acetate and 0.05 mL of saturated Na2CO3 solution were added. After intense stirring, the organic phase was dried (Na2SO4), and the solvent was evaporated to afford 6 mg (yield = 8%) of (S)-1d with an enantiomeric excess of 90% (S = 0.07).

2.5. Procedure for the Preparation of the Single Crystals of Optically Active (S)-1c

To 0.32 g of Ca[(S)-1c • H-DBTA]2 (de = 77%) prepared according to the method shown above, 5.0 mL of saturated Na2CO3 solution was added. The aqueous phase was extracted with 2 × 10.0 mL of dichloromethane to afford 60 mg (yield = 13%) of (S)-1c (S = 0.10). Then, the obtained (S)-1c was dissolved in 0.5 mL of toluene. After stirring for 0.5 h at reflux, the solvent was allowed to evaporate over two weeks to give the single crystals of (S)-1c.

2.6. Single-Crystal X-Ray Diffraction Studies

Single crystals of hydroxyphosphine oxide (S)-1c were prepared by recrystallization of toluene.The crystals were taken up in perfluorinated oil, and a suitable single crystal was carefully mounted on the top of a thin glass wire. Data collection was performed with an Oxford Xcalibur 3 instrument equipped with a Spellman generator (50 kV, 40 mA) and a Kappa CCD detector, operating with Mo-Kα radiation (λ = 0.71071 Ǻ).
Data collection and data reduction were performed with the CrysAlisPro 1.171.40.82a software [46]. Absorption correction using the multiscan method [46] was applied. The structures were solved with SHELXS-97 [47] refined with SHELXL-97 [48] and finally checked using PLATON [49]. Details for data collection and structure refinement are summarized in Table 1.
CCDC-2394035 contains supplementary crystallographic data for this compound. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif (accessed on 26 October 2024).

3. Results and Discussion

3.1. Preparation of Racemic Compounds

At first, racemic diethyl and dibutyl α-hydroxy-ethylphosphonates (1a and 1b, respectively), as well as diphenyl-, bis(4-methylphenyl)- and bis(3,5-dimethylphenyl)-α-hydroxyethylphosphine oxides (1c, 1d and 1e, respectively), were synthesized according to the method previously described by Wang et al. [50] and us [51] (Scheme 1).
The acetaldehyde and diethyl or dibutyl phosphite or diarylphosphine oxides were reacted in the presence of triethylamine catalyst in ethyl acetate as the medium. The solvent was evaporated, and the obtained crude products were purified by column chromatography or, in the case of compounds 1c and 1e, by recrystallization.
Hydroxyphosphine oxides 1c and 1e crystallized out from the reaction mixture. The solid was filtered out; then, it was dissolved in toluene, and charcoal was added. Then, the mixture was stirred at reflux. Cooling followed by removing the crystals by filtration, afforded the corresponding products.
Hydroxyethylphosphonates 1a and 1b, as well as hydroxyethylphosphine oxides 1d and 1e, are known compounds. Thus, they were identified by 31P NMR shifts and HRMS. Their purity was determined by HPLC-MS. α-Hydroxyethyl-bis(3,5-dimethylphenyl)phosphine oxide (1e) is a new compound that was fully characterized by NMR and MS.

3.2. Optical Resolution of Hydroxyphosphine Oxides 1c–e

Dimethyl α-hydroxy-arylmethylphosphonates were successfully resolved into enantiomers using the acidic calcium salt of O,O′-dibenzoyl-(2R,3R)-tartaric acid (Ca(H-DBTA)2) (2) as the resolving agent [37]. Ca(H-DBTA)2 (2) was prepared by the reaction of O,O′-dibenzoyl-(2R,3R)-tartaric acid monohydrate and calcium oxide according to the procedure reported earlier [40]. The optical resolution of the racemic α-hydroxyethyl-diarylphosphine oxides (1c–e) was attempted using 0.25 equiv. of Ca(H-DBTA)2 (2) or Ca(H-DpTTA)2 (3) in various solvents (Table 2).
The nature of the solvents used for resolution may strongly influence chiral discrimination [52]. The solvent can be incorporated into the diastereomer and thus change the structure of the supramolecule being built [53,54]. Earlier, good results have been obtained with ketone- (e.g., acetone or ethyl-methyl-ketone) and ester- (typically ethyl acetate) type solvent [37]. The role of solvents in chiral discrimination was first studied for racemic α-hydroxyethyl-diphenylphosphine oxide (1c). Three different cases may be distinguished, i.e., (1) there is no diastereomeric complex formation (e.g., in THF, acetonitrile, or DMSO) (Table 2, Entries 1–3), (2) there is complex formation, but without chiral discrimination (e.g., in ethyl-methyl-ketone or EtOAc-MeOH or dioxane) (Table 2, Entries 4–6), or (3) there is a real optical resolution (e.g., in EtOAc-EtOH/nPrOH/iPrOH/nBuOH) (Table 2, Entries 7–10). Ethyl acetate proved to be a suitable solvent, but the solubility of the racemates was limited in it; therefore, there arose a need for different alcohols as co-solvents. It was found that, in the presence of methanol, a diastereomeric complex was formed but without chiral discrimination (Table 2, Entry 6). However, the experiments were successful using EtOH, nPrOH, iPrOH, or nBuOH (Table 2, Entries 7–10). In these cases, the crystalline diastereomeric complex with a composition of Ca[(S)-1c • H-DBTA]2 could be isolated by filtration. (In this phase, the establishment of the absolute configuration was tentative.)
The enantiomeric excess of the crystals was determined by chiral HPLC. Using ethanol as the co-solvent, after the crystallization step, the diastereomer was obtained in a yield of 48%, with a de of 38% (Table 2, Entry 7, and Scheme 2). In the case of PrOH, iPrOH, and BuOH, after the crystallization step, the de was better (50%, 45%, and 50%, respectively), but the yields were rather low as compared to those obtained using ethanol (8%, 16%, and 15%, respectively) (Table 2, Entries 8–10). For this reason, in these cases, we did not further purify the diastereomeric salt. Considering all results, ethanol gave the best yield and enantiomeric excess among the alcohols tested. The resolvability (S) was the best in this case. The diastereomer was purified by recrystallization using the same solvent mixture (EtOAc-EtOH), which afforded Ca[(S)-1c • H-DBTA]2 with a de of 77%, in a yield of 28% (Table 2, Entry 7, and Scheme 2).
For α-hydroxyethyl-bis(4-methylphenyl)phosphine oxide 1d, the EtOAc-EtOH solvent system, which worked well for the diphenyl derivative 1c, was used. In this case, no crystalline precipitation was observed with Ca(H-DBTA)2 (Table 2, Entry 11). The optical resolution of α-hydroxyethyl-bis(4-methylphenyl)phosphine oxide 1d was also attempted with the calcium salt of O,O′-di-p-tolyl-(2R,3R)-tartaric acid (Ca(H-DpTTA)2) (3). In this case, there was precipitation of a diastereomeric salt, characterized by a chiral discrimination of de 40%, a yield of 46%, and a S value of 0.18. The complex filtered off was recrystallized twice from the EtOAc-EtOH solvent mixture to provide a de of 90% (Table 2, Entry 12, and Scheme 3).
The optical resolution of α-hydroxyethyl-bis(3,5-dimethylphenyl)phosphine oxide 1e with Ca(H-DBTA)2 or Ca(H-DpTTA)2 was also attempted using the EtOAc-EtOH solvent mixture. In this case, the racemic compound crystallized out; therefore, no chiral discrimination could be observed. Methyl-ibutyl-ketone (MIBK) and DMSO were also tried as solvents for the optical resolution of compound 1e. Using MIBK, there were crystals, but it included hydroxyphosphine oxide 1e as its racemate, whereas no crystalline product was formed in DMSO.
Hydroxyphosphine oxide 1e could not be resolved with either Ca(H-DBTA)2 or Ca(H-DpTTA)2. It seems that the racemic species 1e is much more stable than the corresponding diastereomeric complexes. HPLC-MS analysis confirmed that no diastereomeric complexes were formed, and rather the racemic compound 1e crystallized out from the mixture.
The crystals of α-hydroxyethyl-diphenylphosphine oxide 1c suitable for single-crystal X-ray analysis were obtained from the sample prepared above by dissolving it in toluene and allowing the solvent to evaporate slowly. Decomposition of the Ca[(S)-1c • H-DBTA]2 complex with saturated Na2CO3 solution, followed with extraction with dichloromethane, led to an enantiomeric mixture of α-hydroxyethyl-diphenylphosphine oxide 1c with an enantiomeric excess of 77% in yield of 13%. Single crystals of (S)-1c (with the assumed SC configuration) were prepared from this enantiomeric mixture (Scheme 2).
The Ca[(S)-1d • H-DpTTA]2 complex was decomposed with a saturated Na2CO3 solution, and the obtained material was then extracted with ethyl acetate. Thus, α-hydroxyethyl-bis(4-methylphenyl)phosphine oxide (1d) was obtained in an ee value of 90% and in a yield of 8%.
The absolute configuration of the major enantiomer of α-hydroxyethyl-bis(4-methylphenyl)phosphine oxide (1d) was substantiated comparing the elution sequences observed for the enantiomers of substrates 1c and 1d in chiral HPLC. The SC assignment may be regarded as tentative.
Interestingly, in the case of the Ph group-containing hydroxyphosphine oxide (1c), the optical resolution was successful using Ca(H-DBTA)2, which also contains a phenyl group. In the case of the 4-MePh-containing derivative (1d), the p-tolyl-containing Ca(H-DpTTA)2 resolving agent was found to be the suitable resolving agent.
Unfortunately, this method was not suitable for the optical resolution of dialkyl hydroxyethylphosphonates 1a and 1b. Neither the application of Ca(H-DBTA)2 nor that of Ca(H-DpTTA)2 was accompanied by the precipitation of crystals. The reason for the failure may be explained by the lack of aromatic units.
In the course of the formation of coordination complexes of a similar type, π-π, π-ortho aromatic CH, or π-para aromatic CH connections were substantiated [37]. This intermolecular interaction, of course, has an effect on the chiral discriminating ability of the diastereomer complex or salt. The π-π stacking may be of utmost importance from the point of view of the stability of the intermolecular associate and its chiral discriminating ability [55,56,57,58].

3.3. X-Ray Analysis of the Optically Active 1c

The molecular structure of phosphine oxide 1c as well as the S-configuration of the chiral carbon atom were clearly confirmed by the result of a single-crystal X-ray diffraction study. The compound crystallizes in the monoclinic space group P21 with two molecules in the unit cell. The molecular structure of (S)-1c is displayed in Figure 1. Both phosphorus and the adjacent chiral carbon atom display tetrahedral coordination with a staggered arrangement of the substituents with two oxygen atoms (at phosphorus and of the OH group) in trans position to each other. Atom distances and bond angles are as expected (Supplementary Material Tables S1 and S2).
In the crystal, (S)-1c forms strong hydrogen bonds involving the oxygen atom of the phosphorus and the OH group at the chiral carbon atom (D-H: 0.844 (31) Å, H···A: 1.763 (29) Å, D···A: 2.594 (2) Å, D-H···A: 168 (3)°). The hydrogen bonding interaction results in the formation of chains along the b-axis (Figure 2). This feature corresponds to that observed in the crystal structures of other α-hydroxyalkylphosphine oxides [59,60,61,62,63] and seems to be a general property of compounds of this type.
Figure 1. Molecular structure of compound (S)-1c in the crystal. DIAMOND [64] representation; thermal ellipsoids are drawn at 50% probability level.
Figure 1. Molecular structure of compound (S)-1c in the crystal. DIAMOND [64] representation; thermal ellipsoids are drawn at 50% probability level.
Symmetry 16 01557 g001

4. Conclusions

Two alkyl α-hydroxyethylphosphonates and three α-hydroxyethyl-diarylphosphine oxides were synthesized in the racemic form by the Pudovik reaction of acetaldehyde and diethyl or dibutyl phosphite, as well as diphenylphosphine oxide, bis(4-methylphenyl)phosphine oxide, or bis(3,5-dimethylphenyl)phosphine oxide. The optical resolution of two α-hydroxyethyl-diarylphosphine oxides (aryl = Ph and 4-MePh) was elaborated via diastereomer complex formation applying the acidic calcium salt of O,O-dibenzoyl-(2R,3R)-tartaric acid and O,O′-di-p-tolyl-(2R,3R)-tartaric acid as the resolving agents. The role of the solvent in the enantiomeric discrimination was also investigated. Among the tested solvents, the ethyl acetate–ethanol solvent mixture proved to be the most effective. After purification by recrystallization and decomposition of the corresponding diastereomers, the α-hydroxyethyl-diarylphosphine oxides were obtained with an enantiomeric excess of 77% and 90%, respectively.
It was observed that the model compounds containing aryl ring (s) were successful objects for the optical resolution with the acidic calcium salts of O,O′-dibenzoyl-(2R,3R)-tartaric acid derivatives. This underlines the importance of π-π stackings and other interactions with the participation of the aromatic ring (s).
The structure of the (S)-α-hydroxyethyl-diphenylphosphine oxide was proven by single-crystal X-ray analysis, while the absolute configuration of (S)-α-hydroxyethyl-bis(4-methylphenyl)phosphine oxide (1d) was substantiated in an empirical way. However, the SC assignment may be regarded as tentative.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/sym16111557/s1, Geometrical data for (S)-α-hydroxyethyl-diphenylphosphine oxide ((S)-1c) obtained from the X-ray measurements; 31P, 13C, and 1H NMR spectra for the hydroxyphosphonate derivatives 1a-e synthesized.

Author Contributions

Conceptualization, G.K. and J.S.; methodology, Z.S. and J.S.; investigation, Z.S., A.S.K., J.S. and K.K.; resources, G.K., K.K. and J.S.; data curation, J.S. and K.K.; writing—original draft preparation, G.K., Z.S. and J.S.; writing—review and editing, G.K. and J.S.; supervision, G.K. and J.S.; project administration, G.K.; funding acquisition, G.K. All authors have read and agreed to the published version of the manuscript.

Funding

This project was supported by the National Research, Development and Innovation Office (K134318) and the Doctoral Excellence Fellowship Programme (DCEP) funded by the National Research Development and Innovation Fund of the Ministry of Culture and Innovation and the Budapest University of Technology and Economics, under a grant agreement with the National Research, Development and Innovation Office. The publication as well as the scientific results presented in its context were made with the support of the Gedeon Richter Talentum Foundation established by Gedeon Richter Plc. (1103 Budapest, Gyömrői út 19–21) with the support of the Gedeon Richter Excellence PhD Scholarship.

Data Availability Statement

The data presented in this study are available on request from the corresponding authors.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Patel, D.V.; Rielly-Gauvin, K.; Ryono, D.E.; Free, C.A.; Rogers, W.L.; Smith, S.A.; DeForrest, J.M.; Oehl, R.S.; Petrillo, E.W. Alpha-hydroxy phosphinyl-based inhibitors of human renin. J. Med. Chem. 1995, 38, 4557–4569. [Google Scholar] [CrossRef] [PubMed]
  2. Song, H.; Mao, H.; Shi, D. Synthesis and herbicidal activity of α-hydroxy phosphonate derivatives containing pyrimidine moiety. Chin. J. Chem. 2010, 28, 2020–2024. [Google Scholar] [CrossRef]
  3. Pokalwar, R.U. Synthesis and antibacterial activities of α-hydroxyphosphonates and α-acetyloxyphosphonates derived from 2-chloroquinoline-3-carbaldehyde. Arkivoc 2006, 11, 196–204. [Google Scholar] [CrossRef]
  4. Kategaonkar, A.H.; Pokalwar, R.U.; Sonar, S.S.; Gawali, V.U.; Shingate, B.B.; Shingare, M.S. Synthesis, in vitro antibacterial and antifungal evaluations of new α-hydroxyphosphonate and new α-acetoxyphosphonate derivatives of tetrazolo [1, 5-a] quinoline. Eur. J. Med. Chem. 2010, 45, 1128–1132. [Google Scholar] [CrossRef]
  5. Sampath, C.; Raju, C.N.; Rao, C.V. An efficient synthesis, spectral characterization, anti-microbial and anti-oxidant activities of novel α-hydroxyphosphonates and α-hydroxyphosphinates. Phosphorus Sulfur Silicon Relat. Elem. 2015, 191, 95–99. [Google Scholar] [CrossRef]
  6. Rádai, Z.; Windt, T.; Nagy, V.; Füredi, A.; Kiss, N.Z.; Randelovic, I.; Tóvári, J.; Keglevich, G.; Szakács, G.; Tóth, S. Synthesis and anticancer cytotoxicity with structural context of an α-hydroxyphosphonate based compound library derived from substituted benzaldehydes. New J. Chem. 2019, 43, 14028–14035. [Google Scholar] [CrossRef]
  7. Kalla, R.M.N.; Lee, H.R.; Cao, J.; Yoo, J.-W.; Kim, I. Phospho sulfonic acid: An efficient and recyclable solid acid catalyst for the solvent-free synthesis of α-hydroxyphosphonates and their anticancer properties. New J. Chem. 2015, 39, 3916–3922. [Google Scholar] [CrossRef]
  8. Blaser, H.-U. Chirality and its implications for the pharmaceutical industry. Rend. Fis. Acc. Lincei 2013, 24, 213–216. [Google Scholar] [CrossRef]
  9. Nguyen, L.A.; He, H.; Pham-Huy, C. Chiral drugs: An overview. Int. J. Biomed. Sci. 2006, 2, 85–100. [Google Scholar]
  10. Gröger, H.; Vogl, E.M.; Shibasaki, M. New catalytic concepts for the asymmetric aldol reaction. Chem. Eur. J. 1998, 4, 1137–1141. [Google Scholar] [CrossRef]
  11. Kolodiazhnyi, O.I. Chiral hydroxy phosphonates: Synthesis, configuration and biological properties. Russ. Chem. Rev. 2006, 75, 227–253. [Google Scholar] [CrossRef]
  12. Kolodiazhnyi, O.I. Asymmetric synthesis of hydroxyphosphonates. Tetrahedron Asymmetry 2005, 16, 3295–3340. [Google Scholar] [CrossRef]
  13. Kozma, D. CRC Handbook of Optical Resolutions via Diastereomeric Salt Formation; CRC Press: Boca Raton, FL, USA, 2001. [Google Scholar]
  14. Fogassy, E.; Nógrádi, M.; Kozma, D.; Egri, G.; Pálovics, E.; Kiss, V. Optical resolution methods. Org. Biomol. Chem. 2006, 4, 3011–3030. [Google Scholar] [CrossRef] [PubMed]
  15. Yoshioka, R. Racemization, Optical Resolution and Crystallization-Induced Asymmetric Transformation of Amino Acids and Pharmaceutical Intermediates. In Novel Optical Resolution Technologies; Springer: Berlin/Heidelberg, Germany, 2007; pp. 83–132. [Google Scholar]
  16. Faigl, F.; Schindler, J.; Fogassy, E. Advantages of Structural Similarities of the Reactants in Optical Resolution Processes. In Novel Optical Resolution Technologies; Springer: Berlin/Heidelberg, Germany, 2007; pp. 133–157. [Google Scholar]
  17. Murakami, H. From Racemates to Single Enantiomers—Chiral Synthetic Drugs over the last 20 Years. In Novel Optical Resolution Technologies; Springer: Berlin/Heidelberg, Germany, 2007; pp. 273–299. [Google Scholar]
  18. Kolodyazhnaya, A.O.; Kukhar, V.P.; Kolodyazhnyi, O.I. Organic catalysis of phospha-aldol condensation. Russ. J. Gen. Chem. 2008, 78, 2043–2051. [Google Scholar] [CrossRef]
  19. Hirashima, S.-I.; Arai, R.; Nakashima, K.; Kawai, N.; Kondo, J.; Koseki, Y.; Miura, T. Asymmetric hydrophosphonylation of aldehydes using a cinchona-diaminomethylenemalononitrile organocatalyst. Adv. Synth. Catal. 2015, 357, 3863–3867. [Google Scholar] [CrossRef]
  20. Uraguchi, D.; Ito, T.; Ooi, T. Generation of chiral phosphonium dialkyl phosphite as a highly reactive P-nucleophile: Application to asymmetric hydrophosphonylation of aldehydes. J. Am. Chem. Soc. 2009, 131, 3836–3837. [Google Scholar] [CrossRef]
  21. Abell, J.P.; Yamamoto, H. Catalytic enantioselective pudovik reaction of aldehydes and aldimines with tethered bis (8-quinolinato) (TBOx) aluminum complex. J. Am. Chem. Soc. 2008, 130, 10521–10523. [Google Scholar] [CrossRef]
  22. Deng, T.; Cai, C. Bis (oxazoline)-copper catalyzed enantioselective hydrophosphonylation of aldehydes. RSC Adv. 2014, 4, 27853–27856. [Google Scholar] [CrossRef]
  23. Muthupandi, P.; Sekar, G. Synthesis of an unusual dinuclear chiral iron complex and its application in asymmetric hydrophosphorylation of aldehydes. Org. Biomol. Chem. 2012, 10, 5347. [Google Scholar] [CrossRef]
  24. Sun, L.; Guo, Q.-P.; Li, X.; Zhang, L.; Li, Y.-Y.; Da, C.-S. C2-symmetric homobimetallic zinc complexes as chiral catalysts for the highly enantioselective hydrophosphonylation of aldehydes. Asian J. Org. Chem. 2013, 2, 1031–1035. [Google Scholar] [CrossRef]
  25. Guin, J.; Wang, Q.; van Gemmeren, M.; List, B. The catalytic asymmetric abramov reaction. Angew. Chem. Int. Ed. 2015, 54, 355–358. [Google Scholar] [CrossRef] [PubMed]
  26. Goulioukina, N.S.; Bondarenko, G.N.; Bogdanov, A.V.; Gavrilov, K.N.; Beletskaya, I.P. Asymmetric hydrogenation of α-keto phosphonates with chiral palladium catalysts. Eur. J. Org. Chem. 2009, 2009, 510–515. [Google Scholar] [CrossRef]
  27. Nesterov, V.; Kolodiazhnyi, O. New method for the asymmetric hydroboration of ketophosphonates and the synthesis of phospho-carnitine. Tetrahedron Asymmetry 2006, 17, 1023–1026. [Google Scholar] [CrossRef]
  28. Nesterov, V.; Kolodiazhnyi, O. New method for the asymmetric reduction of ketophosphonates. Phosphorus Sulfur Silicon Relat. Elem. 2008, 183, 687–688. [Google Scholar] [CrossRef]
  29. Skropeta, D.; Schmidt, R.R. Chiral, non-racemic α-hydroxyphosphonates and phosphonic acids via stereoselective hydroxylation of diallyl benzylphosphonates. Tetrahedron Asymmetry 2003, 14, 265–273. [Google Scholar] [CrossRef]
  30. Pogatchnik, D.M.; Wiemer, D.F. Enantioselective synthesis of α-hydroxy phosphonates via oxidation with (camphorsulfonyl)oxaziridines. Tetrahedron Lett. 1997, 38, 3495–3498. [Google Scholar] [CrossRef]
  31. Kafarski, P.; Lejczak, B. Application of bacteria and fungi as biocatalysts for the preparation of optically active hydroxyphosphonates. J. Mol. Catal. B Enzym. 2004, 29, 99–104. [Google Scholar] [CrossRef]
  32. Pàmies, O.; Bäckvall, J.-E. An efficient route to chiral α- and β-hydroxyalkanephosphonates. J. Org. Chem. 2003, 68, 4815–4818. [Google Scholar] [CrossRef]
  33. Li, Y.-F.; Hammerschmidt, F. Enzymes in organic chemistry, part 1: Enantioselective hydrolysis of α-(acyloxy)phosphonates by esterolytic enzymes. Tetrahedron Asymmetry 1993, 4, 109–120. [Google Scholar] [CrossRef]
  34. Demizu, Y.; Moriyama, A.; Onomura, O. Nonenzymatic kinetic resolution of racemic α-hydroxyalkanephosphonates with chiral copper catalyst. Tetrahedron Lett. 2009, 50, 5241–5244. [Google Scholar] [CrossRef]
  35. Kaboudin, B.; Alavi, S.; Kazemi, F.; Aoyama, H.; Yokomatsu, T. Resolution of racemic α-hydroxyphosphonates: Bi(OTF)3-catalyzed stereoselective esterification of α-hydroxyphosphonates with (+)-dibenzoyl-l-tartaric anhydride. ACS Omega 2019, 4, 15471–15478. [Google Scholar] [CrossRef] [PubMed]
  36. Rádai, Z.; Kiss, N.Z.; Czugler, M.; Karaghiosoff, K.; Keglevich, G. The typical crystal structures of a few representative α-aryl-α-hydroxyphosphonates. Acta Crystallogr. Sect. C Struct. Chem. 2019, 75, 283–293. [Google Scholar] [CrossRef] [PubMed]
  37. Rádai, Z.; Bagi, P.; Czugler, M.; Karaghiosoff, K.; Keglevich, G. Optical Resolution of Dimethyl α-Hydroxy-Arylmethylphosphonates via Diastereomer Complex Formation Using Calcium Hydrogen O,O′-Dibenzoyl-(2R,3R)-Tartrate; X-Ray Analysis of the Complexes and Products. Symmetry 2020, 12, 758. [Google Scholar] [CrossRef]
  38. Bagi, P.; Ujj, V.; Czugler, M.; Fogassy, E.; Keglevich, G. Resolution of P-stereogenic P-heterocycles via the formation of diastereomeric molecular and coordination complexes (a review). Dalton Trans. 2016, 45, 1823–1842. [Google Scholar] [CrossRef] [PubMed]
  39. Varga, B.; Herbay, R.; Székely, G.; Holczbauer, T.; Madarász, J.; Mátravölgyi, B.; Fogassy, E.; Keglevich, G.; Bagi, P. Scalable Enantiomeric Separation of Dialkyl-Arylphosphine Oxides Based on Host–Guest Complexation with TADDOL Derivatives, and their Recovery. Eur. J. Org. Chem. 2020, 2020, 1840–1852. [Google Scholar] [CrossRef]
  40. Ujj, V.; Schindler, J.; Novák, T.; Czugler, M.; Fogassy, E.; Keglevich, G. Coordinative resolution of 1-phenyland 1-naphthyl-3-methyl-3-phospholene 1-oxides with calcium hydrogen O,O′-dibenzoyl-(2R,3R)-tartrate or calcium hydrogen O,O′-di-p-toluyl-(2R,3R)-tartrate. Tetrahedron Asymmetry 2008, 19, 1973–1977. [Google Scholar] [CrossRef]
  41. Zhao, Z.; Xue, W.; Gao, Y.; Tang, G.; Zhao, Y. Copper-Catalyzed Synthesis of α-Hydroxy Phosphonates from H-Phosphonates and Alcohols or Ethers. Chem. Asian J. 2013, 8, 713–716. [Google Scholar] [CrossRef]
  42. Mary, F.; Arrachart, G.; Leydier, A.; Pellet-Rostaing, P. Synthesis of organophosphorus ligands with a central oxygen atom and their applications in solvent extraction. Tetrahedron 2019, 75, 3968–3976. [Google Scholar] [CrossRef]
  43. Emoto, T.; Gomi, H.; Yoshifuji, M.; Okazaki, R.; Inamoto, N. Metal Phosphinylides and Phosphinothioylides. I. Formation of Metal Diphenylphosphinylides and Diphenylphosphinothioylides and the Reactions with Some Organic Halides and Aldehydes. Bull. Chem. Soc. Jpn. 1974, 47, 2449–2452. [Google Scholar] [CrossRef]
  44. Stankevic, M.; Pisklak, J.; Wlodarczyk, K. Aryl group—A leaving group in arylphosphine oxides. Tetrahedron 2016, 72, 810–824. [Google Scholar] [CrossRef]
  45. Li, B.; Liu, M.; Rehman, S.U.; Li, C. Rh-Catalyzed Regio- and Enantioselective Allylic Phosphinylation. J. Am. Chem. Soc. 2022, 144, 2893–2898. [Google Scholar] [CrossRef] [PubMed]
  46. Program Package. CrysAlisPro 1.171.40.82a; Rigaku Oxford Diffraction: The Woodlands, TX, USA, 2020. [Google Scholar]
  47. Sheldrick, G.M. SHELXS-97; Program for Crystal Structure Solution; University of Göttingen: Göttingen, Germany, 1997. [Google Scholar]
  48. Sheldrick, G.M. SHELXL-97; Program for the Refinement of Crystal Structures; University of Göttingen: Göttingen, Germany, 1997. [Google Scholar]
  49. Spek, A.L. PLATON; A Multipurpose Crystallographic Tool; Utrecht University: Utrecht, The Netherlands, 1999. [Google Scholar]
  50. Wang, W.; Zhang, S.S.; Zhou, Y.; Peng, H.; He, H.W.; Lu, X.T. Synthesis and Herbicidal Activity of α-(Substituted Phenoxybutyryloxy or Valeryloxy)alkylphosphonates and 2-(Substituted Phenoxybutyryloxy)alkyl-5,5-dimethyl-1,3,2-dioxaphosphinan-2-one. J. Agric. Food Chem. 2016, 64, 6911–6915. [Google Scholar] [CrossRef] [PubMed]
  51. Keglevich, G.; Rádai, Z.; Kiss, N.Z. To date the greenest method for the preparation of α-hydroxyphosphonates from substituted benzaldehydes and dialkyl phosphites. Green Process. Synth. 2017, 6, 197–201. [Google Scholar] [CrossRef]
  52. Sakai, K.; Sakurai, R.; Hirayama, N. Molecular Mechanisms of Dielectrically Controlled Resolution (DCR). In Novel Optical Resolution Technologies. Topics in Current Chemistry; Springer: Berlin/Heidelberg, Germany, 2007; Volume 269. [Google Scholar] [CrossRef]
  53. Toda, F. Optical resolutions by inclusion complexation with a chiral host compound. In Enantiomer Separation; Springer: Berlin/Heidelberg, Germany, 2004; pp. 1–47. [Google Scholar]
  54. Tanaka, K.; Honke, S.; Urbanczyk-Lipkowska, Z.; Toda, F. New Chiral Hosts Derived from Dimeric Tartaric Acid: Efficient Optical Resolution of Aliphatic Alcohols by Inclusion Complexation. Eur. J. Org. Chem. 2000, 2000, 3171–3176. [Google Scholar] [CrossRef]
  55. Bálint, J.; Egri, G.; Czugler, M.; Schindler, J.; Kiss, V.; Juvancz, Z.; Fogassy, E. Resolution of α-phenylethylamine by its acidic derivatives. Tetrahedron Asymmetry 2001, 12, 1511–1518. [Google Scholar] [CrossRef]
  56. Bereczki, L.; Bombicz, P.; Bálint, J.; Egri, G.; Schindler, J.; Pokol, G.; Fogassy, E.; Marthi, K. Optical resolution of 1-(1-naphthyl)ethylamine by its dicarboxylic acid derivatives: Structural features of the oxalic acid derivative diastereomeric salt pair. Chirality 2009, 21, 331–338. [Google Scholar] [CrossRef]
  57. Bálint, J.; Schindler, J.; Egri, G.; Hánusz, M.; Marthi, K.; Juvancz, Z.; Fogassy, E. Resolution of methyl-1-phenylethylamines by acidic derivatives of 1-phenylethylamine. Tetrahedron Asymmetry 2004, 15, 3401–3405. [Google Scholar] [CrossRef]
  58. Tiekink, E.R.T.; Zukerman-Schpector, J. The Importance of Pi-Interactions in Crystal Engineering: Frontiers in Crystal Engineering; Wiley: Hoboken, NJ, USA, 2012. [Google Scholar]
  59. Lemouzy, S.; Nguyen, D.H.; Camy, V.; Jean, M.; Gatineau, D.; Giordano, L.; Naubron, J.-V.; Vanthuyne, N.; Herault, D.; Buono, G. Stereospecific Synthesis of α- and β-Hydroxyalkyl P-Stereogenic Phosphine–Boranes and Functionalized Derivatives: Evidence of the P=O Activation in the BH3-Mediated Reduction. Chem. Eur. J. 2015, 21, 15607–15621. [Google Scholar] [CrossRef]
  60. Mo, X.; Xie, Y.; Wei, L.; Gu, X.; Zhang, M.; Zhang, X.; Jiang, J. Visible-Light-Induced Carbene Insertion into P–H Bonds between Acylsilanes and H-Phosphorus Oxides. Org. Lett. 2023, 25, 2338–2343. [Google Scholar] [CrossRef]
  61. Liu, W.-Y.; Huo, P.; Huang, T.-L.; Mei, G.-Q. (2,4-Dichlorophenyl)(diphenylphosphoryl)methanol. Acta Cryst. 2010, 66, o477. [Google Scholar] [CrossRef]
  62. Lan, K.; Chen, X.-L. Crystal structure of (diphenylphosphinoyl)phenylmethanol, C19H17O2P. Z. Für Krist. New Cryst. Struct. 2006, 221, 171–172. [Google Scholar] [CrossRef]
  63. Priya, S.; Balakrishna, M.S.; Mague, J.T.; Mobin, S.M. Insertion of Carbon Fragments into P(III)−N Bonds in Aminophosphines and Aminobis(phosphines):  Synthesis, Reactivity, and Coordination Chemistry of Resulting Phosphine Oxide Derivatives. Crystal and Molecular Structures of (Ph2P(O)CH2)2NR (R = Me, nPr, nBu), Ph2P(O)CH(OH)nPr, and cis-[MoO2Cl2{(Ph2P(O)CH2)2NEt-κO,κO}]. Inorg. Chem. 2003, 42, 1272–1281. [Google Scholar] [CrossRef]
  64. DIAMOND; Version 3.2i; Crystal Impact GbR: Bonn, Germany, 2014.
Scheme 1. Synthesis of racemic diethyl and dibutyl α-hydroxyethylphosphonates (1a and 1b), as well as α-hydroxyethyl-diarylphosphine oxides (1ce).
Scheme 1. Synthesis of racemic diethyl and dibutyl α-hydroxyethylphosphonates (1a and 1b), as well as α-hydroxyethyl-diarylphosphine oxides (1ce).
Symmetry 16 01557 sch001
Scheme 2. Optical resolution of 1c and preparation of α-hydroxyethyl-diphenylphosphine oxide (S)-1c single crystals.
Scheme 2. Optical resolution of 1c and preparation of α-hydroxyethyl-diphenylphosphine oxide (S)-1c single crystals.
Symmetry 16 01557 sch002
Scheme 3. Optical resolution of α-hydroxyethyl-bis(4-methylphenyl)phosphine oxide 1d.
Scheme 3. Optical resolution of α-hydroxyethyl-bis(4-methylphenyl)phosphine oxide 1d.
Symmetry 16 01557 sch003
Figure 2. Crystal structure of compound (S)-1c; view of the H-bonded chain along the b-axis. DIAMOND [64] representation; thermal ellipsoids are drawn at 50% probability level. Symmetry code for the left molecule: 1 − x, 0.5 + y, −z; symmetry code for the right molecule: 1 − x, −0.5 + y, −z.
Figure 2. Crystal structure of compound (S)-1c; view of the H-bonded chain along the b-axis. DIAMOND [64] representation; thermal ellipsoids are drawn at 50% probability level. Symmetry code for the left molecule: 1 − x, 0.5 + y, −z; symmetry code for the right molecule: 1 − x, −0.5 + y, −z.
Symmetry 16 01557 g002
Table 1. Details for X-ray data collection and structure refinement for compound (S)-1c.
Table 1. Details for X-ray data collection and structure refinement for compound (S)-1c.
(S)-1c
Empirical formulaC14H15O2P
Formula mass246.23
T [K]123 (2)
Crystal size [mm]0.20 × 0.10 × 0.05
Crystal descriptioncolorless rod
Crystal systemmonoclinic
Space groupP21
a [Ǻ]7.0846 (2)
b [Ǻ]10.8324 (3)
c [Ǻ]9.1135 (2)
α [°]90.0
β [°]105.677 (3)
γ [°]90.0
V [Ǻ3]673.38 (3)
Z2
ρcalcd. [g cm−3]1.214
μ [mm−1]0.192
F(000)260
Θ range [°]2.99–25.24
Index ranges−10 ≤ h ≤ 10
−15 ≤ k ≤ 15
−13 ≤ l ≤ 13
Reflns. collected13284
Reflns. obsd.3755
Reflns. unique4112
(Rint = 0.0309)
R1, wR2 (2σ data)0.0341, 0.0730
R1, wR2 (all data)0.0402, 0.0763
GOOF on F21.042
Peak/hole [e Ǻ−3]0.293/−0.171
Table 2. Optical resolution experiments for hydroxyphosphine oxides 1c and 1d with Ca(H-DBTA)2 (2) or Ca(H-DpTTA)2 (3) in various solvents.
Table 2. Optical resolution experiments for hydroxyphosphine oxides 1c and 1d with Ca(H-DBTA)2 (2) or Ca(H-DpTTA)2 (3) in various solvents.
CompoundSolventYield (%)de (%)S = [de (%)] × [yield (%)]RemarkEntry
1cTHF---no diastereomeric
complex was formed
1.
MeCN---no diastereomeric
complex was formed
2.
DMSO---no diastereomeric
complex was formed
3.
MEK2000no chiral discrimination4.
EtOAc (10×) + MeOH (2.5×)1900no chiral discrimination5.
1,4-dioxane1400no chiral discrimination6.
EtOAc (10×) + EtOH (2.5×)48 (28 a)38 (77 a)0.18
(0.22 a)
-7.
EtOAc (10×) + PrOH (2.5×)8500.04-8.
EtOAc (10×) + iPrOH (2.5×)16450.07-9.
EtOAc (10×) + BuOH (2.5×)15500.08-10.
1dEtOAc (10×) + EtOH (2.5×)---no diastereomeric
complex was formed
11.
46 b (9 b,c)40 b (90 b,c)0.18 b
(0.08 b,c)
12.
a The yield [%], de [%], and S values refer to the result obtained after recrystallization of the crystalline diastereomer complex. b O,O′-di-p-tolyl-(2R,3R)-tartaric acid (Ca(H-DpTTA)2) was used as the resolving agent. c The yield [%], de [%], and S values refer to the result obtained after recrystallization twice of the crystalline diastereomer complex.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Szalai, Z.; Kis, A.S.; Schindler, J.; Karaghiosoff, K.; Keglevich, G. Synthesis of α-Hydroxyethylphosphonates and α-Hydroxyethylphosphine Oxides: Role of Solvents During Optical Resolution. Symmetry 2024, 16, 1557. https://doi.org/10.3390/sym16111557

AMA Style

Szalai Z, Kis AS, Schindler J, Karaghiosoff K, Keglevich G. Synthesis of α-Hydroxyethylphosphonates and α-Hydroxyethylphosphine Oxides: Role of Solvents During Optical Resolution. Symmetry. 2024; 16(11):1557. https://doi.org/10.3390/sym16111557

Chicago/Turabian Style

Szalai, Zsuzsanna, Anna Sára Kis, József Schindler, Konstantin Karaghiosoff, and György Keglevich. 2024. "Synthesis of α-Hydroxyethylphosphonates and α-Hydroxyethylphosphine Oxides: Role of Solvents During Optical Resolution" Symmetry 16, no. 11: 1557. https://doi.org/10.3390/sym16111557

APA Style

Szalai, Z., Kis, A. S., Schindler, J., Karaghiosoff, K., & Keglevich, G. (2024). Synthesis of α-Hydroxyethylphosphonates and α-Hydroxyethylphosphine Oxides: Role of Solvents During Optical Resolution. Symmetry, 16(11), 1557. https://doi.org/10.3390/sym16111557

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop